Cargando…

Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis

PURPOSE: Breast cancer is a heterogeneous disease usually including four molecular subtypes such as luminal A, luminal B, HER2-enriched, and triple-negative breast cancer (TNBC). TNBC is more aggressive than other breast cancer subtypes. Despite major advances in ER-positive or HER2-amplified breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jinsong, Yang, Jianbo, Chen, Weicai, Wu, Huisheng, Yuan, Zishan, Wang, Kun, Li, Guojin, Sun, Jie, Yu, Limin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478040/ https://www.ncbi.nlm.nih.gov/pubmed/26103053 http://dx.doi.org/10.1371/journal.pone.0129842

Ejemplares similares

siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERK
por: He, Jingsong, et al.
Publicado: (2014)

Clinical efficacy of local targeted chemotherapy for triple-negative breast cancer
por: He, Jinsong, et al.
Publicado: (2011)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
por: Ding, Jia-Han, et al.
Publicado: (2022)

Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research
por: Yan, Shunchao, et al.
Publicado: (2023)

Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer
por: CHEN, WEICAI, et al.
Publicado: (2015)

Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer
por: Fang, Kun, et al.
Publicado: (2022)

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
por: Lin, Cai-Jin, et al.
Publicado: (2023)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Microarray data reveal potential genes that regulate triple-negative breast cancer
por: Pan, Chi, et al.
Publicado: (2022)

Further plans with the Triple GEM in Zürich
por: Ziegler, M
Publicado: (1999)

Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data
por: Chen, James J, et al.
Publicado: (2007)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
por: Chappell, Kevin, et al.
Publicado: (2021)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

RNA Hydrogel Combined with MnO(2) Nanoparticles as a Nano-Vaccine to Treat Triple Negative Breast Cancer
por: Wang, Weicai, et al.
Publicado: (2021)

Normalization for triple-target microarray experiments
por: Martin-Magniette, Marie-Laure, et al.
Publicado: (2008)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
por: Bareche, Y, et al.
Publicado: (2018)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
por: Cattaneo, Daniele, et al.
Publicado: (2021)

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
por: Su, Guan-Hua, et al.
Publicado: (2022)

Exploring Modality Switching Effects in Negated Sentences: Further Evidence for Grounded Representations
por: Hald, Lea A., et al.
Publicado: (2013)

Identifying survival associated morphological features of triple negative breast cancer using multiple datasets
por: Wang, Chao, et al.
Publicado: (2013)

The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
por: Raju, Rajesh, et al.
Publicado: (2014)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers
por: Boukerroucha, Meriem, et al.
Publicado: (2015)

The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease
por: Evans, Andy, et al.
Publicado: (2021)

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations()
por: Conforti, Fabio, et al.
Publicado: (2021)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
por: Turner, Nicholas, et al.
Publicado: (2010)

siRNA-Mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration
por: JingSong, He, et al.
Publicado: (2016)

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
por: Hashmi, Atif Ali, et al.
Publicado: (2014)

Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
por: Derkaoui, Touria, et al.
Publicado: (2016)

Performance evaluation and further development of the PCR and microarray-based Prove-it™ Sepsis assay
por: Tissari, P, et al.
Publicado: (2009)

miR-30a inhibits epithelial-mesenchymal transition and metastasis in triple-negative breast cancer by targeting ROR1
por: Wang, Xin, et al.
Publicado: (2018)

Identify the triple-negative and non-triple-negative breast cancer by using texture features of medicale ultrasonic image: A STROBE-compliant study
por: Chen, Qingyu, et al.
Publicado: (2021)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Identification of key genes as potential biomarkers for triple-negative breast cancer using integrating genomics analysis
por: Zhong, Guansheng, et al.
Publicado: (2020)

Further evidence for the EELL effect
por: Jennings, B K, et al.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_3cs759kfs831ovsdr8t5ogfb74